Search

Search Constraints

You searched for: Author/Creator Zeldenrust, Steven

Search Results

1. Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria. (29th March 2019)

2. Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation. (12th July 2017)

3. Exploring the amyloid proteome in immunoglobulin‐derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry. Issue 7 (30th May 2013)

4. Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival. (16th March 2017)

5. Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type. (16th March 2017)

6. Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis. (March 2018)

7. Induction therapy pre‐autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation. Issue 10 (14th July 2016)

8. Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition. (3rd October 2017)

9. Soluble suppression of tumorigenicity 2 (sST2), but not galactin‐3, adds to prognostication in patients with systemic AL amyloidosis independent of NT‐proBNP and troponin T. Issue 6 (2nd April 2015)

10. Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis. (2nd January 2020)